Revolutionizing Prostate Cancer Diagnosis with PSMA-PET Imaging
Discover the future of prostate cancer diagnosis with PSMA-PET imaging, as Dr. Brian T. Helfand highlights advancements in imaging technologies that promise earlier detection and personalized treatment strategies. Learn how innovative radiotracers and a deeper understanding of tumor biology are set to revolutionize urologic oncology.
New Prevention Strategies Urgently Needed for Prostate Cancer
Prostate cancer research reveals the significant impact of genetic risk and lifestyle factors on early and late prostate cancer death rates. A recent study involving over 19,000 men found a 3-fold increased risk of early death for those at higher genetic risk. Lifestyle choices such as smoking and obesity were also linked to higher risk. Targeted prevention strategies focusing on healthy lifestyle behaviors could potentially prevent 36% of deaths in the higher genetic risk group. The study underscores the importance of lifestyle modifications in reducing prostate cancer risk among individuals with a genetic predisposition.
Study Raises Concerns About Prostate Cancer Screening in Transgender Women
A recent study led by the University of California – San Francisco has raised concerns about the interpretation of standard prostate cancer screening guidelines for transgender women. Transgender women on hormone therapy may show artificially low results on PSA tests, potentially delaying the detection and treatment of prostate cancer. Specific PSA ranges tailored to this population are needed to address the unique challenges faced by transgender women in prostate cancer screening.
New Treatment Option Available for Men with BPH
Learn about a new treatment option for men with BPH, a common prostate condition, as Men’s Health Month kicks off. Dr. Marc Siegel discusses the impact of BPH and the importance of this new treatment. Stay informed and proactive in managing men’s health issues like BPH with consultation from healthcare providers.
2024 Clinical Practice Guideline on Salvage Therapy for Prostate Cancer Released by AUA, ASTRO, and SUO
The 2024 clinical practice guideline on salvage therapy for prostate cancer has been released by the American Urological Association (AUA), in partnership with the American Society for Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO). The guideline emphasizes the importance of balancing undertreatment with overtreatment, utilizing new therapeutic agents and imaging modalities, and optimizing patient selection with evidence-driven prognostic markers to improve oncologic outcomes and maintain the quality of life for these patients.
Understanding Nocturia: Causes, Symptoms, and Treatment Options
Frequent urination at night, known as nocturia, affects about 1 in 3 people over the age of 30. Nocturia can be caused by various factors including medical conditions and lifestyle choices. Seeking medical attention for a proper diagnosis and treatment is advisable for individuals experiencing frequent nighttime urination.